NAKA MASAO

No ORCID on file · 75 papers in corpus · active 2001-2005
2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2005
Il-6 production inhibitors

An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …

2004
Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient

Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …

2004
Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient

Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …

2004
Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient

Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …

2004
Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient

Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …

2004
Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient

Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …

2004
Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient

Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …

2004
Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient

Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …

2004
Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient

Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …

2004
Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient

Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …

2004
Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient

Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …